Cite
HARVARD Citation
Koch, T. et al. (2020). Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Lancet infectious diseases. 20 (7), pp. 827-838. [Online].